Key Event Components

  • Key Event Components (KECs) are used to describe Key Events (KEs) in a computable way, by defining an action, processes, and object term that maps to controlled vocabulary and ontology terms.
  • KECs on this page can be filtered by the action, process, and object terms, as well as by source ontologies.
  • Link to source ontology terms are provided in cases where the URL was available when the ontology terms were added to the AOP-Wiki database.
  • A complete list of all KECs is available in TSV format on the Downloads Page.
Showing 1076 to 1100 of 1145 KECs
Clear Table Filters
ID Action Process Object Associated Key Events (KEs)
70 increased suppression of host defenses (GO:0044414) immune system (UBERON:0002405) 403: Suppression, Immune system
69 increased I-kappaB phosphorylation (GO:0007252) NF-kappa-B inhibitor (PR:000003292) 145: Induction, IKB inhibitory protein
68 decreased lymphocyte (CL:0000542) 168: Decreased, Lymphocytes
67 decreased cytokine production involved in inflammatory response (GO:0002534) 152: Suppression, Inflammatory cytokines
66 decreased I-kappaB kinase/NF-kappaB signaling (GO:0007249) transcription factor NF-kappa-B subunit (PR:000001753) 202: Inhibition, Nuclear factor kappa B (NF-kB)
65 increased glucocorticoid receptor activity (GO:0004883) glucocorticoid receptor (PR:000011406)
64 decreased memory (GO:0007613) 341: Impairment, Learning and memory
63 decreased synaptic signaling (GO:0099536)
62 decreased synapse assembly (GO:0007416) synapse (GO:0045202) 385: Decrease of synaptogenesis
61 decreased glutamate secretion, neurotransmission (GO:0061535) glutamate(1-) (CHEBI:14321) None
60 abnormal dendrite morphogenesis (GO:0048813) dendrite (GO:0030425) 382: Aberrant, Dendritic morphology
59 decreased learning (GO:0007612) 341: Impairment, Learning and memory
58 increased neurodegeneration (MP:0002229) 352: N/A, Neurodegeneration
57 increased cell death (GO:0008219)
56 decreased secretion (GO:0046903) brain-derived neurotrophic factor (PR:000004716) 381: Reduced levels of BDNF
55 decreased gene expression (GO:0010467) brain-derived neurotrophic factor (PR:000004716) 381: Reduced levels of BDNF
54 decreased calcium ion transport (GO:0006816) calcium ion (CHEBI:39124)
53 occurrence seizures (NBO:0000025) 613: Occurrence, Epileptic seizure
52 occurrence excitatory postsynaptic potential (GO:0060079) 682: Generation, Amplified excitatory postsynaptic potential (EPSP)
51 decreased chemical synaptic transmission (GO:0007268) 669: Reduction, Neuronal synaptic inhibition
50 occurrence membrane depolarization (GO:0051899) 616: Occurrence, A paroxysmal depolarizing shift
49 decreased GABA-gated chloride ion channel activity (GO:0022851) chloride (CHEBI:17996)
48 increased GABA receptor binding (GO:0050811) gamma-aminobutyric acid receptor subunit alpha-6 (PR:000007771) 667: Binding at picrotoxin site, iGABAR chloride channel
47 increased GABA receptor binding (GO:0050811) gamma-aminobutyric acid receptor subunit alpha-5 (PR:000007770) 667: Binding at picrotoxin site, iGABAR chloride channel
46 increased GABA receptor binding (GO:0050811) gamma-aminobutyric acid receptor subunit alpha-1 (PR:000007766) 667: Binding at picrotoxin site, iGABAR chloride channel